Clinical Trial Update: Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating FACBC for detecting metastasis in high-risk prostate cancer patients with presumed localized disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FACBC

Snippet

Sponsor: Emory University | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-01-25